Fulcrum Therapeutics, Inc. · NASDAQ:FULC
Tang Capital Management LLC bought 249,946 Fulcrum Therapeutics, Inc. shares (Form 4)
Traded Jul 13 to Jul 15, 2026 · Filed Jul 15, 2026
From Jul 13 to Jul 15, 2026, Tang Capital Management LLC (10% owner) bought 249,946 Fulcrum Therapeutics, Inc. shares at an average US$3.57 for US$891K, leaving 6,913,329 shares. Filed Jul 15, 2026 (Form 4).
- Bought
- 249,946 shares
- Price
- US$3.57 average (US$3.54 to US$3.58)
- Value
- US$891K
- Holding after
- 6,913,329 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 13, 2026 | Common Stock | Buy | 12,966 | US$3.54 | 6,676,349 | Indirect |
| Jul 14, 2026 | Common Stock | Buy | 53,651 | US$3.56 | 6,730,000 | Indirect |
| Jul 14, 2026 | Common Stock | Buy | 75,952 | US$3.58 | 6,805,952 | Indirect |
| Jul 15, 2026 | Common Stock | Buy | 107,377 | US$3.56 | 6,913,329 | Indirect |
Source
Related
- Fulcrum Therapeutics, Inc.
- Tang Capital Management LLC
- Fulcrum Therapeutics, Inc. shareholders
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Bank of America Corp · Aug 3, 2026